MORGAN E. OBRIEN - 02 Dec 2022 Form 4 Insider Report for Anterix Inc. (ATEX)

Role
Executive Chairman, Director
Signature
/s/ Gena Ashe, Attorney-in-Fact
Issuer symbol
ATEX
Transactions as of
02 Dec 2022
Net transactions value
$0
Form type
4
Filing time
06 Dec 2022, 17:36:33 UTC
Previous filing
10 Aug 2022
Next filing
15 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATEX Stock Option (Right to Buy) Award $0 +154,203 $0.000000 154,203 02 Dec 2022 Common Stock 154,203 $49.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the option shares vest and become exercisable on December 2, 2023, with the remaining option shares vesting in 3 equal annual installments thereafter.